Furthermore, CCL26 has also been described as produced by human bronchial epithelial cells (14) and keratinocytes (15) and its imbalanced secretion, probably due to an overexpression of type-2 cytokines, was implicated in atopic dermatitis and asthma (16–18). This evidence concerns the gene CCL26 and atopic eczema.